SEHK:3933Pharmaceuticals
United Laboratories International Holdings (SEHK:3933) Stock Confronts A Brutal Margin Squeeze
United Laboratories International Holdings stock has sagged over the past month, yet the latest H1 2026 report throws investors a very different challenge. The headline is not revenue; it is profit compression. Trailing net profit margin sits at 4.5% compared with 21.7% last year, while basic earnings per share for the latest half year are a modest ¥0.1762 on revenue of ¥6,165.9m.
The market now has to decide whether this sharp squeeze in profitability is a temporary reset or a meaningful...